Примери за използване на Due to adverse events на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
including discontinuation due to adverse events, were also observed in an open label,
of interferon alfa-2b and ribavirin, 6 % discontinued therapy due to adverse events.
however, the discontinuation rates due to adverse events were low with no statistically significant difference.
adolescents 3 to 16 years of age, 6% discontinued therapy due to adverse events.
with an improvement in treatment discontinuation rates due to adverse events.
however, the discontinuation rates due to adverse events were low with no statistically significant difference.
the proportion of patients who discontinued treatment due to adverse events was 7.6% of the placebo+ TCS group,
The proportion of patients who permanently discontinued treatment due to adverse events was 0%,<
age on safety events, there were higher proportions of patients with serious adverse events and discontinuation due to adverse events in the younger age group than in the older age group.
Dose reduction due to adverse events, regardless of causality, occurred in 37.3% of patients receiving Kisqali in the phase III clinical studies regardless of the combination
Discontinued trial due to adverse event or death.
Includes subjects who discontinued due to adverse event, lost to follow-up, or subject withdrawal.
Discontinued due to adverse event(AE).
Discontinued due to adverse event(AE).
Discontinued study/study drug due to adverse event or death‡.
Other includes subjects who discontinued due to adverse event, lost to follow-up, or subject withdrawal.
Includes subjects who discontinued due to adverse event, lost to follow-up
D Includes patients who discontinued due to adverse event(AE) or death at any time point from day 1 through the time window if this resulted in no virologic data on treatment during the specified window.
DIncludes patients who discontinued due to adverse event or death at any time point from day 1 through the week 24 window resulting in no virologic data on treatment during the specified window.
DIncludes patients who discontinued due to adverse event(AE) or death at any time point from day 1 through the time window if this resulted in no virologic data on treatment during the specified window.